BUHLMANN Citations Archives - Page 6 of 14 - Buhlmann Diagnostics Corp

Category: BUHLMANN Citations

A number of the publications in the citation list describe applications that are outside of product claims thus they should be used for information only.

Towards a Clinical Validation of the BÜHLMANN Flow CAST® Basophil Activation Test for Drug and Protein Allergy

Flow CAST® Assay: Schneider M, Eberlein B, Léon Suárez I, Hausmann O, Wolanczyk-Medrala A, Medrala W, Romano A, Seneviratne S, Snorton A, Niederberger C, Jermann T. Towards a clinical validation of the BÜHLMANN Flow2 CAST® basophil activation test for drug and protein allergy. Poter XXV. EAACI annual meeting, Warsaw, 06.-10. June 2009. Highlights from this Publication
Continue Reading

Immunological Characterization of Dutch Sesame Seed-Allergic Patients

Flow CAST® Assay: Teodorowicz M. et al, Immunological Characterization of Dutch Sesame Seed-Allergic Patients. Int Arch Allergy Immunol 2016;169:13–22.  PMID: 26954556 DOI: 10.1159/000443641. Highlights from this Publication “..In this study, the BAT assay gave an added value to the ImmunoCAP inhibition experiments and Western blot analysis in determinating the clinical relevance and immunological cross-reactivity profile of IgE-sensitized
Continue Reading

The Basophil Activation Test Confirms Milk Allergy in Non Sensitized Children with Allergy Symptoms.

Flow CAST® Assay: Grandné V, Agabriel C, Sainte-Laudy J, Fabre A, Deneux I, Sarles J, Bongrand P, Vitte J. The basophil activation test confirms milk allergy in non sensitized children with allergy symptoms. EAACI Congress 2012, 16.-20. June, Geneva, Switzerland / Poster Abstract No 365. Highlights from this Publication “..BAT brought the biological proof of food
Continue Reading

Benefit of the Basophil Activation Test in Deciding When to Reintroduce Cow’s Milk in Allergic Children

Flow CAST® Assay: Rubio A, Vivinus-Nébot M, Bourrier T, Saggio B, Albertini M, Bernard A. Benefit of the basophil activation test in deciding when to reintroduce cow's milk in allergic children. Allergy. 2011 Jan;66(1):92-100. PubMed PMID: 20608919.  doi: 10.1111/j.1398-9995.2010.02432.x Highlights from this Publication “..this study indicates that the BAT is a valuable tool in helping to decide
Continue Reading

Evaluation of Natural Purified Peanut Allergens for the Use in Diagnosis with Basophil Activation Test

Flow CAST® Assay Schneider M, Shreffler WG, Jermann T. Evaluation of natural purified Peanut allergens for the use in diagnosis with Basophil activation test. EAACI Congress 2012, 16.-20. June, Geneva, Switzerland / Poster Abstract No 1447. Highlights from this Publication “..Component resolved diagnosis with purified peanut allergens provides insights into individual sensitivity of patients to single
Continue Reading

Correlations Between Basophil Activation, Allergen-Specific IgE with Outcome and Severity of Oral Food Challenges

Flow CAST® Assay: Song Y, Wang J, Leung N, Wang LX, Lisann L, Sicherer SH, Scurlock AM, Pesek R, Perry TT, Jones SM, Li XM. Correlations between basophil activation, allergen-specific IgE with outcome and severity of oral food challenges. Ann Allergy Asthma Immunol. 2015 Apr;114(4):319-26. PubMed PMID: 25841330.  doi: 10.1016/j.anai.2015.01.006 Highlights from this Publication “..These results indicate
Continue Reading

Ulcerative Colitis Study: Correlation of Faecal Calprotectin with Histological Nancy Index

BÜHLMANN IBDoc®: Walsh, A, Kormilitzin, A. et al. New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC).  13th Congress of ECCO 2018, Feb 14 – 17, 2018. Vienna, Austria. Highlights from this Poster “Conclusions. An FCal <180 g/g is indicative of endoscopic and histological remission. FCal
Continue Reading

Home-based Fecal Calprotectin Testing: A Canadian User Performance Evaluation Study of IBDoc®

BÜHLMANN IBDoc®: Wong, A, Bourdages, R. et al. Home-based Fecal Calprotectin Testing: A Canadian User Performance Evaluation Study of IBDoc®.  CDDW 2018, Feb 09 – 11, 2018. Toronto, ON Canada. Highlights from this Publication “Conclusions. The IBDoc® test kit was understood by participants, with a majority of participants finding it easy to use, with an
Continue Reading

Fecal Calprotectin Measurement is a Marker of Short-Term Clinical Outcome and Presence of Mucosal Healing in Patients with Inflammatory Bowel Disease

BÜHLMANN fCAL® ELISA: A.Kostas, S.I. Siakavellas, et al. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World Journal of Gastroenterology; November 2017. PMID: 29151692 DOI: 10.3748/wjg.v23.i41.7387. Highlights from this Publication “In our patient cohort, we were able to define an optimal cut-off FC value of 261 µg/g, which had a
Continue Reading

Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study

BÜHLMANN fCAL® ELISA Citation:  Beswick, L. et al. Exploration of predictive biomarkers of early infliximab response in acute severe colitis: A prospective pilot study.  Journal of Crohn's and Colitis. 2017 Nov 7. DOI: 10.1093/ecco-jcc/jjx146.  PMID:  29121178 . Highlight from this Publication “In ASUC, post-first dose IFX, early assessment of serum/faecal IFX, calprotectin and partial Mayo scores can accurate predict future
Continue Reading